AARDEX Group

AARDEX Adherence M&S center used to differentiate between once- and twice-daily dosing in oral anticoagulation

Drug_Discovery
Compelling data presented at the 27th edition of JESFC, Paris, January 13, 2017

JAN-2017 : Compelling data presented at the 27th edition of JESFC, Paris, January 13, 2017.

Journées Européennes de la Société Française de Cardiologie 2017 (JESFC-2017)

Les anticoagulants oraux directs : des preuves d’aujourd’hui aux attentes de demain

Share This Post

You may also like...

Breaking News

Is Neglecting Medication Adherence in Neurology Drug Trials Putting Patients at Risk?

The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological

Bias in clinical Research
Breaking News

Unmasking Bias in Clinical Research: A Historical Perspective

It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,